deltatrials
Completed NA NCT02724475

Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized Controlled Trial

Sponsor: Eastern Hepatobiliary Surgery Hospital

Conditions Hepatocellular Carcinoma Laser Ablation Portal Vein Tumor Thrombus
Interventions 3D-CRT LA
Updated 4 times since 2017 Last updated: Mar 28, 2016 Started: Dec 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2015

A NA clinical study on Hepatocellular Carcinoma and Laser Ablation, this trial is completed. The trial is conducted by Eastern Hepatobiliary Surgery Hospital and has accumulated 4 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2017 — Jan 2021 [monthly]

    Completed NA

    First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eastern Hepatobiliary Surgery Hospital
Data source: Eastern Hepatobiliary Surgery Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Shanghai, China